DAT extreme-deviation burden

Biomarker1 paper1 finding

  • Humans1

Upstream

1

Intermediate amyloid burden

upin humans1

1 study
  1. Intermediate amyloid burden increases DAT extreme-deviation burden in humans (difference = 0.032, q = 0.044).

    Humanscognitively unimpaired with intermediate amyloid burden (10 <= CL < 30) vs amyloid-positive (CL >= 30)

    Normative brain models reveal dopamine shifts in early amyloid · bioRxiv · 29 Sep 2026 · Preprint

Intermediate amyloid burden →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 1Oct 2026: 01
bioRxivHumansPreprint

Normative brain models reveal dopamine shifts in early amyloid

In cognitively unimpaired older adults, intermediate amyloid burden showed lower dopamine-transporter deviation scores than amyloid-positive status…In cognitively unimpaired older adults, intermediate amyloid burden showed lower dopamine-transporter deviation scores than amyloid-positive status, with an adjusted difference of −0.582.